Adelaide Research & Scholarship: Search

Search

Search:
for

Current filters:

Start a new search

Add filters:

Results/Page | Sort items by In order Authors/record

Results 11-20 of 28 (Search time: 0.002 seconds).

Item hits:

Preview	Issue Date	Title	Author(s)
	2011	Relationship between single nucleotide polymorphisms and haplotypes in DPYD and toxicity and efficacy of capecitabine in advanced colorectal cancer	Deenen, M.; Tol, J.; Burylo, A.; Doodeman, V.; de Boer, A.; Vincent, A.; Guchelaar, H.; Smits, P.; Beijnen, J.; Punt, C.; Schellens, J.; Cats, A.
	2013	Pharmacovigilance in hospice/palliative care: net effect of haloperidol for delirium	Crawford, G.; Agar, M.; Quinn, S.; Phillips, J.; Litster, C.; Michael, N.; Doogue, M.; Rowett, D.; Currow, D.
	2014	Nutlin-3a efficacy in sarcoma predicted by transcriptomic and epigenetic profiling	Pishas, K.; Neuhaus, S.; Clayer, M.; Schreiber, A.; Lawrence, D.; Perugini, M.; Whitfield, R.; Farshid, G.; Manavis, J.; Chryssidis, S.; Mayo, B.; Haycox, R.; Ho, K.; Brown, M.; D'Andrea, R.; Evdokiou, A.; Thomas, D.; Desai, J.; Callen, D.; Neilsen, P.
	2015	A phase I/II trial of BNC105P with everolimus in metastatic renal cell carcinoma	Pal, S.; Azad, A.; Bhatia, S.; Drabkin, H.; Costello, B.; Sarantopoulos, J.; Kanesvaran, R.; Lauer, R.; Starodub, A.; Hauke, R.; Sweeney, C.; Hahn, N.; Sonpavde, G.; Richey, S.; Breen, T.; Kremmidiotis, G.; Leske, A.; Doolin, E.; Bibby, D.; Simpson, J.; et al.
	2015	TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets	Yeung, D.; Osborn, M.; White, D.; Branford, S.; Braley, J.; Herschtal, A.; Kornhauser, M.; Issa, S.; Hiwase, D.; Hertzberg, M.; Schwarer, A.; Filshie, R.; Arthur, C.; Kwan, Y.; Trotman, J.; Forsyth, C.; Taper, J.; Ross, D.; Beresford, J.; Tam, C.; et al.
	2012	Impact of age on choice of chemotherapy and outcome in advanced colorectal cancer	Khattak, M.; Townsend, A.; Beeke, C.; Karapetis, C.; Luke, C.; Padbury, R.; Maddern, G.; Roder, D.; Price, T.
	2011	Efficacy of α-lactalbumin and milk protein on weight loss and body composition during energy restriction	Soenen, S.; Hochstenbach-Waelen, A.; Westerterp-Plantenga, M.
	2013	Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17	Vickers, M.; Karapetis, C.; Tu, D.; O'Callaghan, C.; Price, T.; Tebbutt, N.; van Hazel, G.; Shapiro, J.; Pavlakis, N.; Gibbs, P.; Blondal, J.; Lee, U.; Meharchand, J.; Burkes, R.; Rubin, S.; Simes, J.; Zalcberg, J.; Moore, M.; Zhu, L.; Jonker, D.
	2010	Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer	Peeters, M.; Price, T.; Cervantes, A.; Sobrero, A.; Ducreux, M.; Hotko, Y.; Andre, T.; Chan, E.; Lordick, F.; Punt, C.; Strickland, A.; Wilson, G.; Ciuleanu, T.; Roman, L.; Van Cutsem, E.; Tzekova, V.; Collins, S.; Oliner, K.; Rong, A.; Gansert, J.
	2010	Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian gastrointestinal trials group randomized phase III MAX study	Tebbutt, N.; Wilson, K.; Gebski, V.; Cummins, M.; Zannino, D.; van Hazel, G.; Robinson, B.; Broad, A.; Ganju, V.; Ackland, S.; Forgeson, G.; Cunningham, D.; Saunders, M.; Stockler, M.; Chua, Y.; Zalcberg, J.; Simes, R.; Price, T.